This SWOT Analysis company profile is a crucial resource for industry executives and anyone looking to quickly understand the key information concerning AAIPharma Inc.’s business.

Business Review’s “AAIPharma Inc. SWOT Analysis & Company Profile” reports utilize a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format.
Business Review strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.

Scope
• Examines and identifies key information and issues about (AAIPharma Inc.) for business intelligence requirements
• Studies and presents AAIPharma Inc.’s strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported.
• The profile contains business operations, the company history, major products and services, prospects, key competitors, structure and key employees, locations and subsidiaries.

Reasons to Buy
• Quickly enhance your understanding of the company.
• Obtain details and analysis of the market and competitors as well as internal and external factors which could impact the industry.
• Increase business/sales activities by understanding your competitors’ businesses better.
• Recognize potential partnerships and suppliers.
• Obtain yearly profitability figures

Key Highlights
AAIPharma Inc. (AAIPharma) is a drug development company engaged in providing services to pharmaceutical, biotechnology and medical device companies. It provides a wide range of services from drug discovery to registering new drug product candidates. The services include analysis, testing, packing, and marketing new products. The company also provides services for infrastructure and clinical data management. It has many facilities in Europe and the U.S. In April 2009, the company entered into a strategic alliance with Emisphere Technologies, Inc. to expand the application of Eligen Technology and drug development services. The company also acquired the Xcelodose 600S system, an advanced and accurate capsule filling equipment, for effective and faster production of clinical trial materials in 2009. AAIPharma is head quartered in North Carolina, the US.